Home › NDC Lookup › RxCUI directory › RxCUI 1792780

20 ML atezolizumab 60 MG/ML Injection — RxCUI 1792780

RxNorm drug concept · Semantic clinical drug
RxCUI 1792780 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1792780
Official name20 ML atezolizumab 60 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatezolizumab 1200 MG per 20 ML Injection; atezolizumab 1200 MG in 20 ML Injection
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)8,313 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atezolizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tecentriq treats several types of cancer — non-small cell lung cancer (both after surgery and when it has spread), extensive-stage small cell lung cancer, liver cancer (hepatocellu...
  • What cancers is Tecentriq actually approved to treat?
  • No — Tecentriq is given as an IV infusion at a clinic or infusion center, not as a pill you take at home. Your first infusion takes about 60 minutes. If you handle that well, later...
  • How is Tecentriq given — do I take a pill at home?
📖 Read our full Atezolizumab Injection guide →

🕸️ Concept Web — How 20 ML atezolizumab 60 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 20 ML atezolizumab 60 MG/ML Injection RxCUI 1792780

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Atezolizumab 1792776
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tecentriq 1792781
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atezolizumab Injection 1792779
    • Atezolizumab Injectable Product 1792778
    • Atezolizumab Injection [Tecentriq] 1792783
    • Tecentriq Injectable Product 1792784
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atezolizumab 60 MG/ML SCDC · 1792777
  • Atezolizumab Injection SCDF · 1792779
  • Atezolizumab Injectable Product SCDG · 1792778

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 1792780 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0917-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1... TECENTRIQ Genentech, Inc. 2016-05-18
50242-0917-86 1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1... TECENTRIQ Genentech, Inc. 2016-08-11
50242-0918-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1... TECENTRIQ Genentech, Inc. 2019-03-08
Observed labelers: Genentech, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9022 Inj, atezolizumab,10 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.